“Hepatic Adverse Effects of Anti-Mycobacterium Tuberculosis Drugs and Their Associations with Various Genetic Variants”, Precis. Med. Com., vol. 2, no. 1, pp. 59–78, Jun. 2022, doi: 10.55627/pmc.002.001.0053.